These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS. KELLERMEYER RW, BRECKENRIDGE RT. J Lab Clin Med; 1965 Feb; 65():307-15. PubMed ID: 14267254 [No Abstract] [Full Text] [Related]
8. [Study of coagulation factors in normal and pathological synovial fluids. Demonstration of a special coagulation factor in certain synovial fluids in rheumatoid arthritis]. Guérin B, Soria C, Kahn MF, de Sèze S. Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):581-7. PubMed ID: 5083694 [No Abstract] [Full Text] [Related]
10. Hageman factor (factor XII) activity in synovial fluid of rheumatoid arthritis patients and its possible pathogenic significance. Szpilmanowa H, Stachurska J. Experientia; 1968 Aug 15; 24(8):784-5. PubMed ID: 5683163 [No Abstract] [Full Text] [Related]
11. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. Forbes CD, Pensky J, Ratnoff OD. J Lab Clin Med; 1970 Nov 15; 76(5):809-15. PubMed ID: 5477337 [No Abstract] [Full Text] [Related]
12. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. RATNOFF OD, DAVIE EW, MALLETT DL. J Clin Invest; 1961 May 15; 40(5):803-19. PubMed ID: 13739760 [No Abstract] [Full Text] [Related]
13. Prospective study of morphology and phagocytosis of synovial fluid monosodium urate crystals in gouty arthritis. Antommattei O, Schumacher HR, Reginato AJ, Clayburne G. J Rheumatol; 1984 Dec 15; 11(6):741-4. PubMed ID: 6520827 [Abstract] [Full Text] [Related]
14. The contact phase of coagulation in the presence of heparin. BLOOM AL. J Clin Pathol; 1962 Nov 15; 15(6):508-10. PubMed ID: 13971779 [Abstract] [Full Text] [Related]
16. [Activity of the contact substance in thromboplastin formation in the full-term newborn infant]. Schettini F, Wierdis T, Lattanzi E, Violante N, Zimbalatti F. Boll Soc Ital Biol Sper; 1966 Aug 31; 42(16):1058-60. PubMed ID: 5969468 [No Abstract] [Full Text] [Related]
17. [The activity of the contact substance in thromboplastin formation in the premature infant]. Schettini F, Violante N, Lattanzi E, Mautone A. Boll Soc Ital Biol Sper; 1966 Aug 31; 42(16):1060-3. PubMed ID: 5969469 [No Abstract] [Full Text] [Related]
18. [Synovial fluid analysis in gout]. Mader R. Harefuah; 1998 Dec 01; 135(11):555-7. PubMed ID: 10911478 [No Abstract] [Full Text] [Related]
19. [Synovial inflammation and coagulation factors. I. General study]. Guérin B, Soria C, Larrieu MJ, Caen J, Kahn MF, Girard ML, Solnica J. Pathol Biol (Paris); 1972 Sep 01; 20(15):689-94. PubMed ID: 4562042 [No Abstract] [Full Text] [Related]
20. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma. SCHIFFMAN S, RAPAPORT SI, WARE AG, MEHL JW. Proc Soc Exp Biol Med; 1960 Dec 01; 105():453-5. PubMed ID: 13747627 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]